Skip to content

Verastem, Inc.

VSTM

CIK 0001526119 · Pharmaceutical Preparations · Nasdaq

← back to feed
Revenue (TTM)
$13.1M
+285.2% YoY Q1 May 2026
Net Income (TTM)
−$213.15M
−60.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$3.39
+17.5% YoY Q1 May 2026
Gross Margin
99.1%
Q1 May 2026
Operating Margin
-1,325.0%
Q1 May 2026
Net Margin
-1,627.3%
Q1 May 2026
Free Cash Flow (TTM)
−$139.9M
Q1 May 2026
Cash
$165.55M
Q1 May 2026
Total Debt
$25.06M
Q1 May 2026
Shares Outstanding
87.87M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings